Ingalls & Snyder »

Immunoprecise Antibodies shares owned by Ingalls & Snyder

Quarter-by-quarter ownership of Immunoprecise Antibodies (IPA) shares owned by Ingalls & Snyder from 13F filings

Historical chart of Ingalls & Snyder investment in Immunoprecise Antibodies

Tip: Access up to 7 years of quarterly data

All positions including Immunoprecise Antibodies held by Ingalls & Snyder consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunoprecise Antibodies by Ingalls & Snyder

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.2M 1.3M 1.71
2023-09-30 $1.9M 1.0M 1.83
2023-06-30 $3.1M 1.1M 2.96
2023-03-31 $2.9M 1.1M 2.77
2022-12-31 $5.1M 970k 5.21
2022-09-30 $3.9M 967k 3.99
2022-06-30 $3.6M 940k 3.80
2022-03-31 $4.8M 932k 5.14
2021-12-31 $4.4M 820k 5.36
2021-09-30 $3.9M 621k 6.22
2021-06-30 $3.6M 601k 6.02
2021-03-31 $5.1M 517k 9.82
2020-12-31 $5.9M 396k 14.95